Opalia

What Opalia does

Opalia is a Montreal-based food technology company founded in September 2020 (originally as BetterMilk Inc., rebranded to Opalia in February 2022) that produces cell-based animal-free dairy using bovine mammary cells grown in bioreactors. The company's proprietary, patent-pending platform isolates mammary cells from cow udders once, feeds the cells a mix of sugars, salts, and amino acids inside bioreactors, and initiates lactation through a fully continuous proprietary process, yielding real milk containing all functional components of conventional dairy — proteins, fats, and sugars — without requiring animals. Unlike precision fermentation approaches that produce individual proteins requiring downstream formulation, Opalia produces complete ready-to-use whole milk that can be sold as fluid or powdered milk or used by partners to manufacture cheese, butter, ice cream, and yogurt without reformulation. The company has also eliminated fetal bovine serum (FBS) from its manufacturing process, replacing it with an FDA-approved substrate that supports both ethical production and a potentially accelerated regulatory path. Opalia operates as a B2B ingredient supplier and technology licensor to the global food industry, with two named engagements currently: a two-year strategic commercial agreement (2026–2027) with Hoogwegt, the world's largest independent dairy supplier active across 130+ countries and six continents, and a paid pilot agreement with the Canadian division of a leading global dairy company. The company is pursuing regulatory clearances across North America (Canada first, then the US), Europe, and Asia, with commercial market entry targeted for 2028. To date, Opalia has raised CAD $5.3 million in total funding across a 2022 pre-seed (Big Idea Ventures, Sustainable Food Ventures), a March 2024 seed of CAD $2 million led by Hoogwegt Group, and an April 2026 seed tranche of CAD $3.2 million led by Nàdarra Ventures, with participation from Investissement Québec, BoxOne Ventures, Cycle Momentum, Spring Capital, UCEED, Anges Quebec, Ahimsa Foundation, Kale United, Big Idea Ventures, Sustainable Food Ventures, and Natural Products Canada. The company is led by co-founders Jennifer Côté (CEO) and Lucas House (Co-Founder/CTO), operates with 1–10 employees, and is headquartered in Montreal, Quebec.

Name

Opalia

Legal name

Opalia Inc.

Website

https://opaliafoods.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Opalia is a Montreal-based food technology company producing cell-based animal-free dairy from bovine mammary cells via bioreactors. It sells whole milk ingredients and licenses its patent-pending platform to dairy and food manufacturers, targeting a 2028 commercial launch.

Ownership category

akta.pro rank

Product category

Cell-Based Dairy / Cellular Agriculture

NAICS

Dairy Product Manufacturing (3115), Fluid Milk Manufacturing (311511)

SIC

Dairy Products (2020)

akta.pro primary industry

Precision-Fermentation Dairy Analogues Processing (Animal-Free Whey/Casein Products) (AFAHAJAJ)

akta.pro secondary industries

Lactose-Free & Reduced-Lactose Fluid Milk Processing (AFAHAAAE), Infant Formula & Specialized Dairy Nutrition Manufacturing (AFAKAKAJ)

Keywords

• Cell-based dairy
• Animal-free milk
• Cultured dairy ingredients
• Cellular agriculture
• Bioreactor dairy production

Headquarters

HQ city

Montreal

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. B2B Ingredient Sales: Opalia operates as a B2B supplier and licensor to the global food industry, selling milk and milk ingredients directly to dairy and food companies. The company produces ready-to-use whole milk that can be sold as fluid or powdered milk, or used by partners to produce cheese, butter, ice cream, and other dairy products without reformulation.
2. Technology Licensing: Positioning as a technology licensor to enable established dairy and food companies to integrate animal-free dairy into existing products and supply chains using Opalia's proprietary platform.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Opalia produces real dairy milk using immortalized bovine mammary cells grown in bioreactors, eliminating the need for cows while delivering all functional components of conventional milk (proteins, fats, and sugars). The company operates as a B2B ingredient supplier and technology licensor, selling whole milk and milk ingredients to dairy and food manufacturers for downstream production of cheese, butter, ice cream, yogurts, and other dairy applications without reformulation.

Product overview

Opalia operates as a B2B ingredient platform producing cell-based whole milk from immortalized bovine mammary cells. The company's core product is whole milk containing all functional components of traditional dairy (proteins, fats, and sugars), which serves as the foundational input for a range of downstream products including cheese, butter, ice cream, cream, and yogurts. Opalia's proprietary, patent-pending technology uses a modular bioreactor production system to manufacture milk through a continuous process, eliminating the need for cows while maintaining dairy functionality. The company positions itself as a supplier and licensor to the global food industry rather than a consumer-facing brand.

Differentiator

Problem solved

Functional benefit

Products and services

• Cell-Based Whole Milk Real whole milk produced from immortalized bovine mammary cells grown in bioreactors, containing all functional components of traditional dairy (proteins, fats, and sugars). Sold as fluid or powdered milk to dairy and food companies for use in downstream dairy applications.
• Cell-Based Dairy Ingredients B2B ingredient platform supplying milk proteins, fats, and sugars to food and dairy manufacturers for use in producing cheese, butter, ice cream, yogurts, and other dairy products without reformulation. Ready-to-use whole milk integrates seamlessly into existing dairy supply chains.

Quantifiable outcome

• Eliminates methane emissions from dairy production process
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• HoogwegtcoreStrategic or Co-development Partner · 5 August 2025Two-year strategic commercial agreement (2026-2027) to create world's first cell-based dairy products. Hoogwegt, the world's largest independent dairy supplier active in 130+ countries, serves as both investor and commercial partner. Combines Opalia's proprietary cell-based dairy manufacturing technology with Hoogwegt's global markets expertise.
• Cycle MomentumminorStrategic or Co-development PartnerExisting investor and partner, included in both 2024 and 2026 funding rounds. Partner organization supporting sustainable food innovation.
• Government of QuebeccoreOthersPartner through Impulsion PME program managed by Investissement Québec. Minister Pierre Fitzgibbon noted alignment with goal of making Québec the first carbon-neutral state in the Americas by 2050.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Perfect Day: US-based leader in precision fermentation animal-free whey and casein proteins. Directly competes with Opalia in supplying B2B dairy ingredients to food manufacturers seeking animal-free dairy functionality, though using a different (precision fermentation) technology platform.
• Wilk (Biomilk): Israel-based cell-cultivated milk and breast milk company using similar cellular agriculture approach to Opalia. Comparable as a direct technology peer pursuing animal-free dairy via cell-based rather than precision fermentation methods.
• TurtleTree Labs: Singapore/US cell-based dairy company using mammary cell technology to produce cell-cultivated milk and milk components. The closest technology peer to Opalia, using a similar biological approach (mammary cell cultivation) to produce functional milk.
• Imagindairy: Israel-based precision fermentation startup producing animal-free dairy proteins for B2B applications. Comparable as a fellow animal-free dairy ingredient supplier with similar B2B go-to-market targeting dairy manufacturers.
• Better Dairy: UK-based precision fermentation company producing animal-free dairy ingredients including casein and whey. Directly comparable as a B2B animal-free dairy ingredient supplier targeting cheese, yogurt, and ice cream applications.
• Remilk: Israel-based precision fermentation company producing animal-free milk proteins for B2B dairy applications. Comparable as a direct competitor targeting the same dairy ingredient replacement market with a similar B2B licensing and ingredient supply model.

Emerging players

• UPSIDE Foods: US-based leader in cultivated meat using cellular agriculture. Comparable as a fellow cellular agriculture company that has navigated novel food regulatory approval (FDA), providing a potential regulatory pathway template relevant to Opalia's cell-based dairy filings.
• SuperMeat: Israel-based cultivated meat company using cellular agriculture. Comparable as a fellow cellular agriculture peer navigating similar regulatory and scale-up challenges, though focused on meat rather than dairy applications.

Broad incumbents

• Danone: Global dairy and plant-based food major with extensive B2B dairy operations and active investments in alternative dairy. Comparable as a likely B2B customer/partner target for Opalia's cell-based dairy ingredients across yogurt and dairy product lines.
• Bel Group (The Laughing Cow): Global dairy incumbent (parent of The Laughing Cow and Babybel) with broad dairy portfolio including cheese and processed dairy products. Comparable as a large established dairy customer target for Opalia's B2B cell-based dairy ingredient platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/opaliafoods
• Xx.com/Opaliafoods

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds5 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Opalia